Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New blood test spots deadly liver cancer early

NCT ID NCT07225452

First seen Nov 06, 2025 · Last updated May 20, 2026 · Updated 27 times

Summary

This study tested a new blood test to detect intrahepatic cholangiocarcinoma, a rare and aggressive liver cancer. Researchers looked for tiny particles called exosomal miRNAs in the blood of 535 adults. The goal was to see if this non-invasive test could accurately identify cancer patients and help diagnose the disease earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAHEPATIC CHOLANGIOCARCINOMA (ICC) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    Duarte, California, 91016, United States

Conditions

Explore the condition pages connected to this study.